Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Environment
Pfizer has set up a collaboration with Entelos, a Foster City, Calif.-based computer modeling company, and four major research universities: Caltech; MIT; the University of Massachusetts; and the University of California, Santa Barbara. Together they will study insulin signaling in adipose (or fat) cells with the goals of understanding diabetes and obesity and finding new drug targets. In the first phase, researchers at Pfizer, MIT, and UMass will collect and analyze data, which will then be fed to computational groups at MIT, Caltech, and UCSB. Pfizer is funding the initial three-year, $14 million insulin resistance pathway project. If it is successful, a second, two-year program will look at other insulin-sensitive tissues.
This article has been sent to the following recipient: